CIK 0001279704 · Non-accelerated filer<br>Smaller reporting company
Cellectar Biosciences, Inc.
Sign in to watch- Ticker
- CLRB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 043321804
- Phone
- (608) 441-8120
- Business address
- 100 CAMPUS DRIVE, FLORHAM PARK, NJ, 07932
- Former names
- NOVELOS THERAPEUTICS, INC., COMMON HORIZONS INC
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Other events
- 4 Grant or award Chief Commercial Officer acquired 39,599 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 42,554 shares (grant or award)
- 4 Grant or award Senior Vice President, Medical acquired 47,856 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 42,927 shares (grant or award)
- 4 Grant or award President and CEO acquired 40,596 shares (grant or award)
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- 8-K Event Bylaws or fiscal year change · Shareholder vote results · Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-3/A Offering Registration Statement
- UPLOAD Other SEC-generated Letter
Page 9 of 61 · 1,218 filings